DataMEDS AI Inc.
MEDS | NASDAQ
$1.92
-$0.11 (-5.42%)
At close: Oct 30, 2026, 4:00 PM ET
$1.93
+$0.01 (+0.52%)
Pre-market:
Nov 2, 2026, 9:26 AM ET
-5.42%
(1D)No price chart data available for 1D timeframe.
Rating
14.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1019/1028 (Top 99%)
Key Statistics
Market Data
Market Cap $8.63M
1D Range
1.86 1.98
52W Range
0.85 34.96
Valuation (TTM)
PE -0.04
PB -0.44
EV/EBITDA -0.69
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -157.5%
SBC Adj. FCF Yield -489.7%
SBC Impact -210.9%
Margins
Gross Margin -125.1%
Operating Margin -719.3%
FCF Margin -169.3%
Growth (CAGR)
Revenue 3Y | 5Y -68.8% |
N/A
Dil EPS 3Y | 5Y -44.5% |
N/A
FCF 3Y | 5Y -123.0% |
N/A
Returns
ROA -269.5%
ROE 877.6%
ROIC -439.9%
Financial Health
Net Debt
$30.17M
Current Ratio 0.14
Interest Coverage -9.72
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intell...
Sector Healthcare
Industry Medical - Distribution
Employees 31
IPO Date Feb 21, 2025
Website datamedsai.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove MEDS